Integration Contract Clauses (8,130)
Grouped Into 152 Collections of Similar Clauses From Business Contracts
This page contains Integration clauses in business contracts and legal agreements. We have organized these clauses into groups of similarly worded clauses.
Integration. Except as expressly provided in this Amendment, all other terms, conditions and provisions of the Agreement shall continue in full force and effect as provided therein. This Amendment and the Agreement constitute the entire agreement between the Parties related to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, between the Parties with respect to the subject matter hereof. No subsequent alteration, amendment, change or addition to this
... Agreement shall be binding upon the Parties unless reduced to a writing referencing the Agreement and signed by an authorized officer of each Party.
View More
Integration. Except as expressly provided in this Amendment, all other terms, conditions and provisions of the Agreement
and Amendment No. 1 shall continue in full force and effect as provided therein. This
Amendment, Amendment
No. 1 and the Agreement constitute the entire agreement between the Parties related to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, between the Parties with respect to the subject matter hereof. No subsequent alteration,
... amendment, change or addition to this Agreement Amendment shall be binding upon the Parties unless reduced to a writing referencing the Agreement this Amendment and signed by an authorized officer of each Party.
View More
View Variation
Integration. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreements between the parties concerning such subject matter, including, without limitation, the Prior Employment Agreement. -13- 13. Successors. This Agreement shall inure to the benefit of and be enforceable by the Executive's personal representatives, executors, administrators, heirs, distributees, devisees and legatees. In the event of the Executive's death
... after his termination of employment but prior to the completion by the Company of all payments due him under this Agreement, the Company shall continue such payments to the Executive's beneficiary designated in writing to the Company prior to his death (or to his estate, if the Executive fails to make such designation). The Company shall require any successor to the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.
View More
Integration. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes
in all respects all prior agreements between the parties concerning such subject
matter, including, matter [including, without limitation, the
Prior Employment Agreement. -13- 13. Successors. Offer Letter. ]1 14. Successor to the Executive. This Agreement shall inure to the benefit of and be enforceable by the Executive's personal representatives, executors,
... administrators, heirs, distributees, devisees and legatees. In the event of the Executive's death after his termination of employment a Terminating Event but prior to the completion by the Company Employers of all payments due him under this Agreement, the Company Employers shall continue such payments to the Executive's beneficiary designated in writing to the Company Employers prior to his death (or to his estate, if the Executive fails to make such designation). The Company shall require any successor to the Company to expressly assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform it if no such succession had taken place.
View More
View Variation
Integration. This Agreement contains the entire agreement between the Company and Employee on the subjects addressed in this Agreement and replaces any other prior agreements or representations, whether oral or written, between them; provided, however, that any proprietary or confidential information agreement Employee signed with the Company, whether or not reaffirmed by Employee, remains in full force and effect and is not superseded by this Agreement.
Integration. This Agreement contains the entire agreement between
Employer and the
Company and Employee on the subjects addressed in this Agreement and replaces any other prior agreements or representations, whether oral or written, between them; provided, however, that any proprietary or confidential information agreement
and/or arbitration agreement Employee signed with
the Company, whether or not reaffirmed by Employee, Employer remains in full force and effect and is not superseded by this Agreement.
View Variation
Integration. This Agreement constitutes a single, integrated written contract expressing the entire agreement of the parties hereto relative to the subject matter hereof. Except as otherwise provided herein, no covenants, agreements, representations, or warranties of any kind whatsoever have been made by any party hereto. All prior discussions and negotiations have been and are merged and integrated into, and are superseded by, this Agreement. This Agreement shall not be amended except by the written
... agreement of all parties hereto.
View More
Integration. This Agreement constitutes a single, integrated written contract expressing the entire agreement of the parties hereto
relative relating to the subject matter hereof.
Except as otherwise provided herein, no No covenants, agreements,
representations, representations or warranties of any kind whatsoever have been made by any party
hereto. All hereto, except as specifically set forth in this Agreement, and all prior
discussions discussions, negotiations and
negotiations agreements, whether written... or oral have been been, and are are, merged and integrated into, and are superseded by, this Agreement. This Agreement shall not be amended except by the written agreement of all parties hereto.
View More
View Variation
Integration. This Note and the Letter Agreement constitutes the entire contract between the Company and the Holder relating to the subject matter hereof and supersedes any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.
Integration. This Note and the
Letter Purchase Agreement
constitutes constitute the entire contract between the Company and the
Holder Seller relating to the subject matter hereof and supersedes any and all previous agreements and understandings, oral or written, relating to the subject matter hereof.
View Variation
Integration. This is an integrated Modification and supersedes all prior negotiations and agreements regarding the subject matter hereof. All amendments hereof must be in writing and signed by the parties.
Integration. This is an integrated Modification and supersedes all prior negotiations and agreements regarding the subject matter hereof. All amendments
hereof hereto must be in writing and signed by the parties.
Integration. This is an integrated Modification and supersedes all prior negotiations and agreements regarding the subject matter hereof. All amendments
hereof hereto must be in writing and signed by the parties.
View Variation
Integration. The Nanomerics License Agreement, as amended by this Amendment, contains the entire agreement of the Parties with regard to this Amendment and the Nanomerics License Agreement, and supersedes and replaces any prior agreements as to that matter. Neither this Amendment nor the Nanomerics License Agreement may be changed or modified, in whole or in part, except by an instrument in writing signed by the Parties. [Remainder of Page Intentionally Left Blank] THIS AMENDMENT IS EXECUTED by the
... authorised representatives of the Parties on the dates indicated below but effective as of the Amendment Effective Date. Signed for and on behalf of Signed for and on behalf of NANOMERICS LTD VIRPAX PHARMACEUTICALS, INC. /s/ Andreas G. Schatzlein /s/ Anthony P. Mack Name: Andreas G. Schatzlein Name: Anthony P. Mack Title: Chief Executive Officer Title: Chairman & Chief Executive Officer Date: 5 Jan 2021 Date: January 5, 2021 -2- EX-10.31 2 fs12021a3ex10-31_virpaxphar.htm AMENDMENT NO. 1 TO THE COLLABORATION AND LICENSE AGREEMENT BETWEEN NANOMERICS LTD. AND VIRPAX PHARMACEUTICALS, INC., DATED AS OF DECEMBER 31, 2020 Exhibit 10.31 AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT BETWEEN NANOMERICS LTD. AND VIRPAX PHARMACEUTICALS, INC. This Amendment to the Collaboration and License Agreement (this "Amendment") is made effective as of December 31, 2020 (the "Amendment Effective Date") between Virpax Pharmaceuticals, Inc. ("Virpax") and Nanomerics Ltd. ("Nanomerics"). Virpax and Nanomerics are each sometimes referred to herein as a "Party" and, collectively, as the "Parties." WHEREAS, Virpax and Nanomerics are parties to that certain Collaboration and License Agreement, dated as August 7, 2020, (the "Nanomerics License Agreement"); WHEREAS, the Parties desire to modify certain terms of the Nanomerics License Agreement as set forth in this Amendment; WHEREAS, any capitalized term not separately defined in this Amendment shall have the meaning ascribed to it in the License Agreement, and NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 1.Amendment. i.The defined term "Funding Expiry Date" in Section 1 of the Nanomerics License Agreement shall be deleted and replaced in its entirety with the following: "Funding Expiry Date" means the date (if any) specified as such in the Funding Plan and as defined in Section Error! Reference source not found, or if no such date is specified the 31st of March 2021.
View More
Integration. The Nanomerics License Agreement, as amended by this Amendment, contains the entire agreement of the Parties with regard to this Amendment and the Nanomerics License Agreement, and supersedes and replaces any prior agreements as to that matter. Neither this Amendment nor the Nanomerics License Agreement may be changed or modified, in whole or in part, except by an instrument in writing signed by the Parties. [Remainder of Page Intentionally Left Blank]
Schedule 4: Licensed Patents – Amended... [Remainder of Page Intentionally Left Blank] THIS AMENDMENT IS EXECUTED by the authorised authorized representatives of the Parties on the dates indicated below but effective as of the Amendment Effective Date. Signed for and on behalf of Signed for and on behalf of NANOMERICS LTD VIRPAX PHARMACEUTICALS, INC. INC /s/ Andreas G. Schatzlein Schätzlein /s/ Anthony P. Mack Christopher Chipman Name: Andreas G. Schatzlein Schätzlein Name: Anthony P. Mack Christopher Chipman Title: Chief Executive Officer Title: Chairman & Chief Executive Officer CFO Date: 5 Jan 15 May 2021 Date: January 5, 2021 -2- EX-10.31 2 fs12021a3ex10-31_virpaxphar.htm 5/5/21 EX-10.4 3 f10q0621ex10-4_virpaxpharma.htm AMENDMENT NO. 1 TO THE COLLABORATION AND LICENSE AGREEMENT DATED APRIL 11, 2019, AS AMENDED, BETWEEN NANOMERICS LTD. AND VIRPAX PHARMACEUTICALS, PHARMACEUTICALS INC., DATED AS OF DECEMBER 31, 2020 MAY 5, 2021 Exhibit 10.31 10.4 SECOND AMENDMENT TO COLLABORATION AND LICENSE AGREEMENT BETWEEN NANOMERICS LTD. AND VIRPAX PHARMACEUTICALS, INC. This Amendment to the Collaboration and License Agreement (this "Amendment") is made effective as of December 31, 2020 5/5/21 (the "Amendment Effective Date") between Virpax Pharmaceuticals, Inc. ("Virpax") and Nanomerics Ltd. ("Nanomerics"). Virpax and Nanomerics are each sometimes referred to herein as a "Party" and, collectively, as the "Parties." WHEREAS, Virpax and Nanomerics are parties to that certain Collaboration and License Agreement, dated as August 7, 2020, (the "Nanomerics License Agreement"); WHEREAS, the Parties desire to modify certain terms of the Nanomerics License Agreement as set forth in this Amendment; WHEREAS, any capitalized term not separately defined in this Amendment shall have the meaning ascribed to it in the License Agreement, Agreement. and NOW, THEREFORE, in consideration of the foregoing premises and the mutual covenants contained herein, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: 1.Amendment. 1. Amendment. i.The defined term "Funding Expiry Date" Schedule 4:Licensed Patents in Section 1 29 of the Nanomerics License Agreement shall be deleted and replaced in its entirety with the following: "Funding Expiry Date" means "Schedule 4:Licensed Patents – Amended" attached below: 2. Term of Amendment. This Amendment shall be in effect from the date (if any) specified as such in Amendment Effective Date and shall continue for the Funding Plan and as defined in Section Error! Reference source not found, or if no such date is specified term of the 31st of March 2021. Nanomerics License Agreement.
View More
View Variation
Integration. This Agreement, together with the Employment Agreement, Inventions Agreement, Indemnity Agreement and the forms of equity award agreements that describe Executive's outstanding Equity Awards, represents the entire agreement and 3Limelight Confidential Information understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral.
Integration. This Agreement, together with the Employment Agreement, Inventions Agreement, Indemnity Agreement and the forms of equity award agreements that
3 Limelight Confidential Information describe Executive's outstanding Equity Awards, represents the entire agreement and
3Limelight Confidential Information understanding between the parties as to the subject matter herein and supersedes all prior or contemporaneous agreements whether written or oral.
View Variation
Integration. This Agreement constitutes the entire agreement between the parties with respect to this Option and supersedes all prior agreements and discussions between the parties concerning such subject matter.8.Tax Withholding. To the extent applicable, the Grantee shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the Committee for payment of any Federal, state, and local
... taxes required by law to be withheld on account of such taxable event. The Company shall have the authority to cause the required tax withholding obligation to be satisfied, in whole or in part, by (i) withholding from Ordinary Shares to be issued to the Grantee a number of Ordinary Shares with an aggregate Fair Market Value that would satisfy the withholding amount due; or (ii) causing its transfer agent to sell from the number of Ordinary Shares to be issued to the Grantee, the number of Ordinary Shares necessary to satisfy the Federal, state and local taxes required by law to be withheld from the Grantee on account of such transfer.9.Data Privacy Consent. In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the "Relevant Companies") may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the "Relevant Information"). By entering into this Agreement, the Grantee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Grantee shall have access to, and the right to change, the Relevant Information. Relevant Information will only be used in accordance with applicable law. 4ACTIVE/105288671.3 10.Notices. Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Grantee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.AVADEL PHARMACEUTICALS PLCBy: Title:The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company's instructions to the Grantee (including through an online acceptance process) is acceptable.Dated: Grantee's Signature Grantee's name and address: 5ACTIVE/105288671.3 10.5.2020 GOODWIN DraftRESTRICTED stock UNIT AWARD AGREEMENTFOR NON-EMPLOYEE DIRECTORSUNDER THE AVADEL PHARMACEUTICALS PLC 2017 OMNIBUS INCENTIVE COMPENSATION PLANName of Grantee: No. of Restricted Stock Units: Grant Date: Pursuant to the Avadel Pharmaceuticals plc 2017 Omnibus Incentive Compensation Plan, as amended through the date hereof (the "Plan"), Avadel Pharmaceuticals plc (the "Company") hereby grants an award of the number of Restricted Stock Units listed above (an "Award") to the Grantee named above. Each Restricted Stock Unit shall relate to one ordinary share, nominal value $0.01, in the capital of the Company (the "Ordinary Shares"). The Ordinary Shares may be represented by American Depositary Shares ("ADSs"), and each ADS represents one Ordinary Share. References herein to the issuance of Ordinary Shares shall also refer to the issuance of ADSs on the same basis of one ADS for every one Ordinary Share.
View More
Integration. This Agreement constitutes the entire agreement between the parties with respect to this Option and supersedes all prior agreements and discussions between the parties concerning such subject matter.8.Tax Withholding. To the extent applicable, the
Grantee Optionee shall, not later than the date as of which the receipt of this Award becomes a taxable event for Federal income tax purposes, pay to the Company or make arrangements satisfactory to the
Committee Administrator for payment of any
... Federal, state, and local taxes required by law to be withheld on account of such taxable event. The Company shall have the authority to cause the required tax withholding obligation to be satisfied, in whole or in part, by (i) withholding from Ordinary Shares to be issued to the Grantee Optionee a number of Ordinary Shares with an aggregate Fair Market Value that would satisfy the withholding amount due; or (ii) causing its transfer agent to sell from the number of Ordinary Shares to be issued to the Grantee, Optionee, the number of Ordinary Shares necessary to satisfy the Federal, state and local taxes required by law to be withheld from the Grantee Optionee on account of such transfer.9.Data Privacy Consent. In order to administer the Plan and this Agreement and to implement or structure future equity grants, the Company, its subsidiaries and affiliates and certain agents thereof (together, the "Relevant Companies") may process any and all personal or professional data, including but not limited to Social Security or other identification number, home address and telephone number, date of birth and other information that is necessary or desirable for the administration of the Plan and/or this Agreement (the "Relevant Information"). By entering into this Agreement, the Grantee Optionee (i) authorizes the Company to collect, process, register and transfer to the Relevant Companies all Relevant Information; (ii) waives any privacy rights the Grantee Optionee may have with respect to the Relevant Information; (iii) authorizes the Relevant Companies to store and transmit such information in electronic form; and (iv) authorizes the transfer of the Relevant Information to any jurisdiction in which the Relevant Companies consider appropriate. The Grantee Optionee shall have access to, and the right to change, the 4ACTIVE/102694809.2 Relevant Information. Relevant Information will only be used in accordance with applicable law. 4ACTIVE/105288671.3 10.Notices. law.10.Notices. Notices hereunder shall be mailed or delivered to the Company at its principal place of business and shall be mailed or delivered to the Grantee Optionee at the address on file with the Company or, in either case, at such other address as one party may subsequently furnish to the other party in writing.AVADEL PHARMACEUTICALS PLCBy: Title:The foregoing Agreement is hereby accepted and the terms and conditions thereof hereby agreed to by the undersigned. Electronic acceptance of this Agreement pursuant to the Company's instructions to the Grantee Optionee (including through an online acceptance process) is acceptable.Dated: Grantee's Optionee's Signature Grantee's Optionee's name and address: 5ACTIVE/105288671.3 10.5.2020 GOODWIN DraftRESTRICTED stock 5ACTIVE/102694809.2 RESTRICTED SHARE UNIT AWARD AGREEMENTFOR NON-EMPLOYEE DIRECTORSUNDER THE AVADEL PHARMACEUTICALS PLC 2017 2020 OMNIBUS INCENTIVE COMPENSATION PLANName of Grantee: No. of Restricted Stock Share Units: Grant Date: Pursuant to the Avadel Pharmaceuticals plc 2017 2020 Omnibus Incentive Compensation Plan, as amended through the date hereof (the "Plan"), Avadel Pharmaceuticals plc (the "Company") hereby grants an award of the number of Restricted Stock Share Units listed above (an "Award") to the Grantee named above. Each Restricted Stock Share Unit shall relate to one ordinary share, nominal value $0.01, in the capital of the Company (the "Ordinary Shares"). The Ordinary Shares may be represented by American Depositary Shares ("ADSs"), and each ADS represents one Ordinary Share. References herein to the issuance of Ordinary Shares shall also refer to the issuance of ADSs on the same basis of one ADS for every one Ordinary Share.
View More
View Variation
Integration. This Amendment, together with the other Loan Documents and the other documents contemplated hereby, contains the final and complete integration of all prior expressions by the parties hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof superseding all prior oral or written understandings.
Integration. This Amendment,
together with the
other Loan Documents Agreement and the other
documents contemplated hereby, contains Transaction Documents contain the final and complete integration of all prior expressions by the parties hereto with respect to the subject matter hereof and shall constitute the entire agreement among the parties hereto with respect to the subject matter hereof superseding all prior oral or written understandings.
View Variation